PE/SEC  Leerink Capital Partners

     Office Locations:

255 California Street, 12th Fl
San Francisco, CA 94111
Phone: 415-905-7226

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.


  • Growth
  • Middle Market



  • Life Sciences & Healthcare



    Founded in 2013, Leerink Capital Partners is an investment arm of Leerink Partners LLC specializing in health-care technology and services and digital health-care investments. There are three subdivisions of Leerink Capital Partners: Leerink Revelation Partners, Leerink Transformation Partners, and Leerink Pharmaceutical Investments. Leerink Revelation Partners focuses on secondary transactions, providing liquidity and capital to existing investors in leading healthcare companies; Leerink Transformation Partners is focused on growth equity investments in privately held innovative companies in the healthcare technology and healthcare services sectors with proven revenue traction, recurring revenue, and high growth potential; and Leerink Pharmaceutical Investments was established in 2014 and is focused on investing in the most innovative, undervalued, and fastest growing global healthcare companies with an emphasis on therapeutic companies.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Jared Kesselheim MD Managing
    Kevin Brown CPA CFO
    Michael Boggs Managing Partner
    Scott Halsted Managing Partner
    Todd Cozzens Managing Partner


    Recent Funding Events (trailing 12 months):










      Series B


      TCR2 Therapeutics



      Series B


      Generation Bio



      Series B


    Portfolio companies include:

        web link

      Generation Bio
        web link

      Health Catalyst
        web link

        web link

        web link
        web link

      TCR2 Therapeutics
        web link

      Vera Whole Health
        web link

      Vertos Medical
        web link


    Recent News: